wiz-icon
MyQuestionIcon
MyQuestionIcon
1
You visited us 1 times! Enjoying our articles? Unlock Full Access!
Question

As with earlier treatments for short stature, the latest wave of drugs has met with a chorus of controversy. The companies argue that their products offer a safe way for parents to insure their children against a lifetime of discrimination in work and romance. Critics are of the opinion that society is buying into the idea that someone who is short has a medical problem _____________________________ .

A
They strongly believe that drug makers are making profit out of a condition that is merely cosmetic.
Right on! Give the BNAT exam to get a 100% scholarship for BYJUS courses
B
They believe that the concerns of the people and the controversy will grow – side by side with revenues – as new drugs hit the market.
No worries! We‘ve got your back. Try BYJU‘S free classes today!
C
They are also troubled by the wide variance in effectiveness.
No worries! We‘ve got your back. Try BYJU‘S free classes today!
D
They believe that the shortness stigma certainly helps the drug companies.
No worries! We‘ve got your back. Try BYJU‘S free classes today!
Open in App
Solution

The correct option is A They strongly believe that drug makers are making profit out of a condition that is merely cosmetic.

option A

[C] can be negated immediately because from the passage it is not clear whether the critics are concerned about the variance in effects of the drugs. The last sentence of the passage indicates that the critics do not approve of the way the companies are making profit out of a normal physical condition. [B] can also be negated because the passage does not indicate anything about the concerns of the people using the drugs. [A] and [D] both may seem plausible. Compared to [D], [A] puts forth the disapproval of the critics in stronger terms.


flag
Suggest Corrections
thumbs-up
0
Join BYJU'S Learning Program
similar_icon
Related Videos
thumbnail
lock
Social Problems
CIVICS
Watch in App
Join BYJU'S Learning Program
CrossIcon